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1. Introduction 
Giant cell arteritis (GCA), also known as temporal arteritis (TA) is a relatively frequent 
primary systemic vasculitis affecting large and medium-sized arteries, in particular aorta 
and its main branches (Hunder, 2000). It occurs, by definition, in patients older than fifty 
with a peak between 70 and 80 years. The disease primarily affects whites, specifically 
those of northern European descent, and the highest worldwide incidence is reported to 
be in southern Norway with 32.8 per 100.000 people over the age of 50 affected (Richards 
et al., 2010). GCA affects women 2–3 times more commonly than men (Richards et al., 
2010).  
The spectrum of clinical manifestations associated with TA includes a wide combination of 
symptoms and signs, ranging from tender and swollen temporal arteries, headache and jaw 
claudication to systemic and musculoskeletal symptoms such as fatigue, weight loss, low-
grade fever, polymyalgia rheumatica, arthralgias and tenosynovitis (Hunder, 2000). 
Irreversible visual loss secondary to ischemic optic neuropathy is the most serious and 
dreaded complication, so prompt diagnosis and treatment are mandatory to prevent it 
(Gonzalez-Gay et al., 2005; Hunder, 2000).  
1.1 Diagnosis of GCA: Current issues 
Although a rapid and non-invasive diagnosis of TA would be desirable, it still remains a 
challenge for clinicians. History, typical clinical findings and elevation of acute phase 
reactants are usually sufficient to induce the suspicion for TA but they are insufficient to 
give diagnostic certainty. The American College of Rheumatology classification criteria 
(ACRC) for GCA (Hunder et al., 1990) help to distinguish TA from other primary 
vasculitides for research purposes, but they have significant limitations in clinical diagnosis 
(Rao et al., 1998). Therefore, temporal artery biopsy (TAB) is still considered the gold 
standard because of its high specificity and it is currently recommended in all suspected 
cases of TA (Drehmer et al., 2005). At present, segments of at least 2.5 cm are considered 
adequate to reduce - but not to completely avoid - the risk of skip lesions (Gonzalez-Gay, 
2005). Since histology can be influenced by corticosteroids, TAB should be performed before 
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starting therapy (Ray-Chaudhuri et al., 2002) but in most cases it is too hazardous to wait 
until biopsy is performed, thus steroids are usually started as soon as GCA is clinically 
suspected (Borg & Dasgupta, 2009). After starting high dose of corticosteroids, TAB can 
remain informative even for up to 4–6 weeks (Achkar et al., 1994; Ray-Chaudhuri et al., 
2002) but it should be performed no later than two weeks ( Borg & Dasgupta, 2009; 
Warrington & Matteson, 2007). 
However TAB implies a number of problems. It is an invasive procedure that may lead to 
some complications (Bhatti & Goldstein, 2001; Haist, 1985; Siemssen, 1987; Slavin, 1986) and 
it is usually available much too late to influence therapeutic decision (Nesher et al., 2004). 
Moreover, TAB may result negative in up to 10%–44% of patients (Hall et al., 1983; Schmidt, 
2006) and in these cases patients should undergo controlateral TAB if clinical suspicion of 
GCA is high (Gonzalez-Gay, 2005). 
On this background, new non-invasive vascular diagnostic techniques, such as ultrasound 
(US) and vascular magnetic resonance imaging (MRI), have gained in the last years a 
growing  interest and an increasing importance in clinical diagnosis (Schmidt, 2004). In 
particular US, whose resolution with regard to superficial anatomical structures is superior 
to that of  MRI, can  provide an excellent evaluation of vessel anatomy and inflammatory 
alterations (Gonzalez-Gay et al., 2006; Schmidt & Blockmans, 2005).  
Regular use of these non invasive imaging modalities in the diagnosis of GCA instead of 
TAB is currently a debated issue.  
2. Ultrasonography in TA 
With the availability of high-resolution Color Doppler (CD) and the high-frequency 
transducers, ultrasonography has became an increasingly powerful tool also for 
rheumatologists (Grassi et al., 2004). High-frequency probes have a resolution of about 
0.1 mm and provide an optimal examination of joints, muscles and tendons (Grassi et al., 
2004; Schmidt, 2004). CD and Color Duplex US (CDUS) offer further benefits over 
conventional Doppler US. CD integrates Doppler effect in the greyscale image as a 
colour signal and allows an accurate study of both small vessels and large arteries 
(Romera-Villegas et al., 2004; Schmidt, 2004; Schmidt & Blockmans, 2005). The  
sensitivity of CD in detecting the small vessels is even more enhanced by the application 
of Power Doppler, which is extremely useful in highlighting the slow blood flow and, 
consequently, it allows to study articular, periarticular and peritendinous inflamed 
tissues more accurately (Grassi et al., 2004; Schmidt, 2004). In addition CD is able to 
depict the wall of large arteries and the associated inflammatory changes in detail, thus 
appearing very useful in the diagnostic assessment of vasculitis (Kissin & Merkel, 2004) 
compared to conventional continuous-wave Doppler, which cannot provide anatomical 
images (Dany et al., 1989; Kelley, 1978; Puechal et al., 1995; Vinckier et al., 1989). CDUS 
offers further benefits over CD. Through a combination of real-time imaging and 
Doppler sonography, it shows at the same time anatomical images with colour signals 
and pulsed-wave Doppler curves, allowing an evaluation of the velocity of blood flow by 
the integration of Doppler shift frequency in combination with an angle correction 
programme (Schmidt & Gromnica-Ihle, 2005). Thus alterations like stenosis and 
occlusions, that frequently occur in acute temporal arteritis, can be evaluated more easily 
(Schmidt & Gromnica-Ihle, 2005). 
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2.1 Sonographic features  
The usefulness of CD and CDUS in the diagnosis of TA was demonstrated in 1995 by 
Schmidt and colleagues (Schmidt et al., 1995). They first described in temporal arteries of 
patients affected by acute TA the ‘halo’ sign, ascribed to oedematous wall swelling and 
characterized by a hypoechoic and circumferential wall thickening localized around the 
perfused lumen with a diameter ranging between 0.3 and 2 mm (Schmidt et al., 1995) 
(Fig.1,2). 
 
Fig. 1. US Color Doppler of the left parietal ramus in acute TA. Longitudinal plane. Very 
high-frequency transducer at 18MhZ (My Lab 70- Esaote). Hypoechoic dark area (“halo”) is 
indicated by the yellow arrows (left side). On the right side: the same arterial segment in the 
greyscale. 
 
 
Fig. 2. US Color Doppler of the right distal third of the common superficial temporal artery 
in acute TA. Transverse plane. Very high-frequency transducer at 18MhZ (Esaote-My Lab 
70). Hypoechoic dark area (“halo”) is indicated by the yellow arrows (right side). On the 
right side: the same arterial segment in the greyscale. 
The other two parameters considered relevant for the diagnosis of TA are stenosis and 
occlusion of the arteries. Stenosis, characterized by a narrowing of the vessel lumen, has 
been defined as a segmental increase in blood flow velocity and two time higher than in the 
area before the stenosis. Other ancillary US features are turbulence of the flow with reduced 
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velocity behind the area of the stenosis and the persistence of the colour signal during 
diastole (Schmidt et al., 1995). Acute temporal artery occlusion is revealed by the complete 
absence of colour signals  in a segment of temporal artery (Schmidt et al., 1995).  
2.2 Sensitivity and specificity of CDUS in TA  
In 1997, Schmidt and coll. published data on the sensitivity and specificity of  CDUS in their 
series of 30 patients with active TA compared with 82 controls, with clinical diagnosis and 
biopsy as reference standard (Schmidt et al., 1997). Diagnosis of TA was confirmed by 
biopsy in 21 of the 30 patients. Hypoechoic halo was evidenced in 22/30 patients with TA; 
stenoses or occlusions in 24/30; stenoses, occlusions, or a halo in 28/30. On the contrary, no 
halo was evidenced in the 82 controls without TA but 6/82 had stenoses or occlusions. With 
regard to clinical diagnosis, sensitivity and specificity for the halo were 73% and 100%, 
whilst for stenosis and/or occlusion were 80% and 93%, respectively. With regard to  
histology, sensitivity and specificity for the halo resulted to be 76% and 92%, while for 
stenosis and/or occlusion were 86% and 88%, respectively. Noteworthy, if halo, stenosis and 
occlusion were considered together, sensitivity resulted higher both vs clinical diagnosis 
(93%) and vs histology (95%).  
These results have been confirmed by the same authors in a larger study on 101 patients 
with acute TA vs 650 controls (Schmidt & Gromnica-Ihle, 2003). Sensitivity  resulted low 
and specificity high vs clinical diagnosis and histology when the halo was considered alone, 
while sensitivity became significantly higher when  halo, stenosis and occlusion were 
considered together (Schmidt & Gromnica-Ihle, 2003). Stenosis alone demonstrated a very 
low sensitivity in TA because it was commonly found even in elderly patients without TA, 
since they are usually affected by arteriosclerosis (Schmidt et al., 1997; Schmidt & Gromnica-
Ihle, 2003, 2005). Conversely acute occlusions, although less frequent than stenosis, were 
more specific for TA being rarely found in patients without TA (Schmidt et al., 1997; 
Schmidt & Gromnica-Ihle, 2003, 2005)  
Since the first description (Schmidt et al., 1997), several studies have been published on the 
diagnostic value of CDUS in TA with similar results (Aschwanden et al., 2010; Bley et al., 
2008; Ghinoi et al., 2008; Houtman et al., 2008; Karahaliou et al., 2006; Lesar et al., 2002; 
Maldini et al., 2010; Morinobu et al., 2011; Murgatroyd et al., 2003; Nesher et al., 2002; Perez 
Lopez et al., 2009; Pfadenhauer & Weber, 2003; Reinhard et al., 2004; Romera-Villegas et al., 
2004; Salvarani et al., 2002; Schmidt, 2000; Schmidt & Gromnica-Ihle, 2003; Suelves et al., 
2010). 
In the 2005, Karassa and coll. published a meta-analysis aimed to review  the diagnostic 
value of CDUS in GCA (Karassa  et al., 2005). The authors selected the most important 
studies published up to 2004. In all these reports, biopsy and the ACRC were used as the 
reference standard. The weighted sensitivity of halo sign resulted 69% (vs biopsy) and 55% 
(vs ACRC), while the specificity was 82% (vs biopsy) and 94% (vs ACRC criteria). Stenosis or 
occlusion showed quite a similar sensitivity (68% vs biopsy and 66% vs ACRC criteria). This 
analysis confirmed the utility of CDUS in diagnosing GCA and the high specificity of the 
halo sign, the detection of which strongly supports the diagnosis of TA. However most of 
the studies included in this meta-analysis were small, of modest quality and with a 
considerable degree of heterogeneity.  
Two further meta-analysis were published more recently in 2010 (Arida et al., 2010; Ball et 
al., 2010). In the first one, the sensitivity and specificity of the halo sign versus the ACRC as 
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a reference standard were examined. (Arida et al., 2010). Eight prospective studies, through 
December 2009, fulfilling technical quality criteria for ultrasound and involving 575 patients 
were finally selected. Compared with final diagnosis, sensitivity and specificity resulted of 
68% and 91% for the presence of unilateral halo, and of 43% and 100% for bilateral halo, 
respectively.  
In the second meta-analysis performed by Ball and coll., (Ball et al., 2010), all studies in 
english language published up to 2009 with a minimum of 5 patients and using TA biopsy 
and/or ACRC criteria as the reference standard were included. When the halo sign  was 
compared with TA biopsy, the weighted sensitivity and specificity  resulted 75% and 83% 
respectively. When the halo sign  was compared with ACR criteria, the weighted sensitivity 
and specificity  resulted 69% and 89% respectively. This study confirms the high specificity 
but also evidenced the higher sensitivity of the halo sign, that may reflect both the 
improvement of the duplex machines and the increased expertise of the ultrasonographers 
(Ball et al., 2010). Very interestingly, when halo, stenosis and occlusion were considered 
together, sensitivity further increased in comparison to TA biopsy and ACR criteria to 83% 
and 78%, respectively (Ball et al., 2010) (Table 1)  
 
CDUS alterations 
Reference 
standard 
Karassa and 
coll. 
Arida and coll. Ball and coll. 
  
Sens. 
(%) 
Spec.
(%) 
Sens. 
(%) 
Spec. 
(%) 
Sens. 
(%) 
Spec. 
(%) 
H TAB 69 82   75 83 
S/O TAB 68      
H + S + O TAB     83 82 
H ACRC 55 94 
68 
(43 if 
bilat.) 
91 
(100 if 
bilat.) 
69 89 
S/O ACRC 66      
H + S + O ACRC     78 88 
Table 1. CDUS signs vs references standard in the 3 meta-analysis. TA: temporal artery; 
ACRC: American College of Rheumatology Criteria. H: Halo; S: Stenosis; O: Occlusion. TAB: 
Temporal Artery Biopsy.  
In summary, all these data confirm that the dark halo is the most specific CDUS sign in 
GCA, so its detection strongly supports a diagnosis of TA in patients with typical clinical 
signs. On the other hand, sensitivity of halo is lower than specificity, so the absence of a halo 
does not exclude TA. If halo, stenosis and occlusions are considered together, the sensitivity 
of CDUS is higher and comparable to histology. 
Interestingly, in the study of Karahaliou (Karahaliou et al., 2006) it has been shown that the 
presence of a bilateral halo sign had a 100% specificity for the diagnosis of TA; this observation 
led the authors to conclude that bilateral “halo sign” may be substitutive of TA biopsy. 
The results of a recent study by Maldini and coll. led to less enthusiastic conclusions about the 
real value of US in GCA (Maldini et al., 2010). Characteristics of US findings with continuous-
wave Doppler or CDUS of temporal arteries was retrospectively evaluated and compared with 
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biopsy and clinical diagnosis. Halo sign showed 100% specificity for GCA but only 10%-17% 
sensitivity; stenoses or occlusions appeared to have low diagnostic power. These data led the 
authors to conclude that US in GCA is neither an effective substitute for biopsy nor a reliable 
screening test to decide which patients can be safely spared from TAB. 
2.3 US in follow-up of TA  
In our experience, CDUS resulted very helpful in the diagnostic work-up, in identifying the 
best target segment to biopsy and in follow-up of patients with TA (Ciancio et al, 2009; 
Fotinidi et al, 2011).  
We performed bilateral CDUS examination to check for the halo thickness, erythrocyte 
sedimentation rate (ESR) and C-reactive protein (CRP)  in a group of 25 patients at baseline 
and after 2, 4 and 6 weeks. Both sensitivity and specificity for the halo resulted very high 
(100%) when compared to clinical diagnosis and biopsy. During follow-up, the halo 
thickness in all the 25 patients disappeared 2-weeks after starting corticosteroids (Fig. 3) and  
 
 
3a (T0) 3b (T2) 
 
3c (T0) 3d (T2) 
Fig. 3. Left parietal ramus of the superficial temporal artery in a patient with acute GCA at 
baseline (T0: on the left) and after two weeks of corticosteroid therapy (T2: on the right). 
High-frequency transducer at 12MhZ (Logic 5 Pro-GE) 
3a. Longitudinal plane. Baseline (T0).The hypoechoic (black) area is indicated by the yellow 
arrows  
3b.Longitudinal plane. Complete remission of the halo after two weeks (T2) of 
corticosteroids  
3c. Transverse Plane of the same segment. Baseline (T0).The hypoechoic (black) area is 
indicated by the yellow arrows  
3d. Transverse Plane. Complete remission of the halo after two weeks (T2) of corticosteroids 
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this modification antedated the normalization of both ESR and CRP thus suggesting that 
CDUS may allow a better monitoring of clinical course and can guide a more careful 
tapering of glucocorticoid therapy (Chart 1). Obviously, this observation needs further 
confirmations in larger series since the role of CDUS in follow-up of TA is still currently 
considered rather doubtful and less useful for monitoring disease activity than the patient’s 
history and/or ESR (Schmidt, 2004). Furthermore, in extracranial GCA the sonographic 
appearance of the arterial wall has not been validated yet as a reliable parameter for the 
assessment of disease activity (Tato & Hoffmann, 2008). Although the halo decreases during 
treatment, some degree of thickening of the arterial wall and stenosis can persist even in 
patients in complete remission, and complete recanalization of occluded arterial segments 
does not always occur (Schmidt & Blockmans, 2005; Tato e& Hoffmann, 2008).  
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Chart 1. Variation of the monitored parameters (ESR and CRP vs HALO) in the 25 patients 
with GCA. ESR and CRP: mean value among the 25 patient at each time point. 
ESR: erythrocyte sedimentation rate. CRP: C-reactive protein 
2.4 Examination technique 
Detailed technical aspects of the examination methodology have been described in an 
excellent review by Schmidt (Schmidt, 2004). Briefly, a high quality CD US equipment and 
standardised US machine adjustments, the use of linear probe with high frequency (>8 
MHz) and a good experience of the operator are indispensable to adequately perform CDUS 
of  temporal arteries.  
2.4.1 US equipment 
Excellent equipment is currently available and provided by different companies. However, 
even the best is likely to be ineffective for an adequate depiction of temporal arteries 
alterations  if right machine settings are missing. A prerequisite to appropriately perform 
CD examination of temporal arteries is the availability of high frequency (>8 MHz) linear 
transducers. The availability of modern probes with frequencies of up to 15 MHz has greatly 
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increased the resolution power for the evaluation of surface anatomical layers. Depending 
on the individual equipment, a too high frequency for the colour image may even reduce 
the sensitivity for the colour, and if grey scale and colour gains are too high or too low, it is 
possible to overlook hypoechoic areas or to generate false hypoechoic areas, respectively 
(Schmidt, 2004). Even the colour sample steering is important; it should have an angle of 20–
30° when a branch parallel to the probe is examined, otherwise the colour signal would not 
be adequate (Schmidt, 2004). Again, pulse repetition frequency (PRF) should be carefully 
regulated to 2–2.5 KHz. Because of  the high blood flow velocities, colour Doppler should be 
preferred to power Doppler since the latter may miss stenoses. 
2.4.2 Experience of the sonographer 
In order to properly examine temporal arteries, a good experience with vascular US should 
be warranted by a trained operator and a perfect knowledge of the US appearance of normal 
temporal arteries is mandatory. Artefacts may occur and the operator must be very familiar 
with them. It has been recommended that a minimum of 50 normal temporal arteries 
examination should be performed before starting to evaluate patients with suspected GCA 
(Schmidt, 2004). Recent experiences with standardized training programs to allow 
rheumatologists to learn the technique for US examination of the temporal arteries have 
shown encouraging results by proving effective and well accepted by the trainees (De 
Miguel et al., 2009) 
2.5 Limits of CDUS in TA  
False-positive and false-negative halos may be seen when performing CDUS. If the common 
superficial TA has an accompanying vein in which no flow is seen, this can be erroneously 
checked for a halo (Schmidt, 2000). False-positive halos are also seen in malignant and 
infectious diseases (Nesher et al., 2002).On the contrary, halo can be missed if a stronger 
colour intensity covering the inflamed wall is employed (Schmidt, 2000). Moreover, about 10 
per cent of patients with a positive biopsy have normal duplex imaging as a result of very 
low inflammatory infiltrate possibly due both to mild disease or prolonged corticosteroid 
treatment (Schmidt, 2004; Weyand & Goronzy, 2003;). It has been demonstrated that CDUS 
findings in active TA do not correlate with occurrence and severity of ophthalmic 
complications (Schmidt et al., 2009). Furthermore, CDUS is not able to differentiate between 
GCA and other vasculitis that can involve temporal arteries, as it can occur in Wegener’s 
granulomatosis, Churg–Strauss syndrome and microscopic polyangiitis (Schmidt & 
Gromnica-Ihle, 2005). 
2.6 US findings in extracranial GCA 
CDUS can also be very useful for diagnosis, assessment of severity and follow-up when 
extracranial large arteries are involved in GCA. (Aschwanden et al., 2010; Kolossvary et al., 
2005; Reinhard et al., 2003; Schmidt et al., 2002; Schmidt et al., 2008;). In brachial, subclavian 
or axillary arteries, CDUS has been shown to be able to demonstrate the typical signs of 
vascular inflammation such as concentric and hypoechogenic wall thickening of arterial 
segments, the narrowing  of the arterial lumen or a hypoechogenic occlusion. (Kolossvary et 
al., 2005; Schmidt et al., 2008). CDUS  signs in association with clinical symptoms and 
elevated laboratory markers of systemic inflammation can be considered diagnostic for 
large-vessel vasculitis making it unnecessary to use of conventional angiography (Tato & 
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Hoffmann, 2008). With regard to the involvement of lower limbs in GCA, CDUS semeiology 
of femoropopliteal and crural arteries appears to be the same as  in the vessels of the upper 
limbs (Aschwanden et al., 2010; Schmidt et al., 2002; Tato & Hoffmann, 2006;) 
3. Other tools for the diagnosis of GCA 
In recent years, other imaging techniques have been proved useful in the diagnosis of TA, 
such as  magnetic resonance imaging (MRI), 18F-fluorodeoxyglucose positron emission 
tomography (FDG-PET), single-photon emission computed tomography (SPECT) and 
computed tomography (CT). High-resolution contrast-enhanced MRI and angio-MRI have 
proved useful in visualizing the involvement of temporal arteries and/or other large arteries 
such as aorta in extracranial GCA (Bley et al., 2005; Narvaez et al., 2005). MRI was also able 
to evidence isolate inflammation of the occipital arteries, with sparing of the temporal 
arteries (Bley et al., 2005).  
The utility of FDG-PET in evaluating the active lesions of large arteries in patients with 
systemic vasculitis  including GCA has recently been demonstrated(Schmidt e Blockmans, 
2005). However, PET is not suitable for the assessment of temporal arteries (Schmidt & 
Blockmans, 2005) but it has proven useful in assessing disease activity during therapy  in 
extracranial GCA (Walter et al., 2005). 
In a pilot study, SPECT revealed positive findings in temporal arteries of nine patients with 
active temporal arteritis (Reitblat et al., 2003). In selected cases, angiography and CT may 
still have a role in investigating the involvement of large extracranial arteries in GCA 
(Stanson, 2000).  
4. Conclusion 
Although, to date, biopsy remains the gold standard for diagnosis of TA, CDUS may be 
considered a very useful tool. It is inexpensive, non-invasive, reproducible and easy-to-
perform. Dark halo is the most specific CDUS sign in GCA, so its detection strongly 
supports a diagnosis of TA in patients with typical clinical signs. Sensitivity of halo is lower 
than specificity, so the absence of a halo does not exclude TA but if halo, stenosis and 
occlusions are simultaneously detected sensitivity of CDUS becomes high and comparable 
to histology. Finally, detection of the halo could allow a guided biopsy with an increased 
probability to avoid false negative results due to skip lesions. Therefore, CDUS should 
precede TA biopsy in all patients with suspected GCA. After initiating therapy, the 
disappearance of the halo has proved to be more sensitive than ESR and CRP. If confirmed 
by other studies, CDUS could be usefully employed also in follow-up allowing a better 
monitoring and tapering of glucocorticoid therapy. The contribution of CDUS is useful also 
for diagnosis, assessment of severity and follow-up in extracranial GCA.  
Some limits of US evaluation should be well kept in mind, such as the possibility of false-
positive and false-negative halos, the lack of correlations with ophthalmic complications and 
the inability to differentiate GCA by other vasculitis. The heavy dependence on operator 
expertise is another critical point to be considered.  
Even if CDUS has gained an emerging role in the diagnostic workup of GCA, larger studies 
are needed in the near future to verify the possibility that this technique may really replace 
the TAB in the diagnostic work-up of TA and that it could be a reliable tool in the follow up 
evaluation. 
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